Research News and Research

RSS

UCB to present new data on Cimzia at ACG annual scientific meeting

UCB, a leading biopharmaceutical company at the forefront of immunology treatment and research, will present new data on Cimzia at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Washington D.C. from October 28 to November 2.

1 Nov 2011

Viewpoints: Judd Gregg on revamping entitlements and taxes; John Breaux on slashing Medicare fraud; Medicaid limits on hospital stays

Consider this. As of this year, every other household in America will have at least one person in it who is receiving an entitlement benefit, according to the Census Bureau. As of this year, fewer than half of the Americans who have earned income will pay income taxes on that income.

1 Nov 2011

Aspirin may reduce risk of bowel cancer by half: Study

According to a new study published in The Lancet, a regular dose of aspirin may not only stave off heart disease but also cut the risk of developing hereditary cancer in half.

31 Oct 2011

A healthy diet may help reduce risk of breast cancer

October was breast cancer awareness month and the long asked question – does diet really influence the risk of breast cancer?, is finally being answered.

31 Oct 2011

Panel backs anthrax vaccine testing on children

An important panel of government advisers Friday recommended that the government should sponsor a controversial study to test the anthrax vaccine in children to see whether the inoculation would protect young Americans against a bioterrorist's attack.

31 Oct 2011

PEPFAR and women's health in South Africa

This report, titled "Improving Women's Heath in South Africa: Opportunities for PEPFAR," by Janet Fleischman of the Center for Strategic and International Studies, says that with "major change ... unfolding in health and HIV services in South Africa," "[t]he United States can find feasible, flexible ways to support" the decentralization of "HIV services to the primary care level ... even though its health program through the President's Emergency Plan for AIDS Relief (PEPFAR) is scaling down.

31 Oct 2011

Child mortality declining in refugee camp in Ethiopia

In the clinic of Hilaweyn, one of four camps at Ethiopia's Dollo Ado complex for Somali refugees seeking relief from famine and poor security conditions, "[a] massive infusion of humanitarian resources ... appears to be turning the tide" against child mortality, according to Doctors Without Borders, which operates the clinic, VOA News reports.

31 Oct 2011

Obama to issue order to address medicine shortages

President Obama will issue an executive order on Monday that the administration hopes will help resolve a growing number of critical shortages of vital medicines used to treat life-threatening illnesses.

31 Oct 2011

New computer-based tool enables early diagnosis of cancer

A computer-based tool could help GPs to speed up the diagnosis and treatment of patients suffering from two of the most common forms of cancer, potentially saving thousands of lives every year.

31 Oct 2011

Insurers look for opportunities for expansion

Big players such as Aetna and Cigna are snapping up smaller companies in an effort to keep earnings figures up.

31 Oct 2011

Leg muscle dysfunction related to severity of symptoms in heart failure patients

Doctors should not only treat the heart muscle in chronic heart failure patients, but also their leg muscles through exercise, say researchers in a study published today in the Journal of Applied Physiology.

31 Oct 2011

Medicare costs rise as hospice use increases

The Orlando Sentinel reports that this increase tracks with other increases in costs from for-profit hospice organizations.

31 Oct 2011

Health insurers defend rate increases

In Maine and New Hampshire, insurance companies are challenging state regulation of rates.

31 Oct 2011

UV light exposure and vitamin D play a potential role in chronic digestive conditions

New research points to a potential role for UV light exposure and vitamin D levels in chronic digestive conditions; Crohn's disease, a serious inflammatory condition in the small intestine; and ulcerative colitis (UC), which similarly affects the colon.

31 Oct 2011

Vegenics receives IND approval from FDA for VGX-100 Phase I study in late stage cancers

Circadian Technologies Limited announces that its 100% owned subsidiary, Vegenics Pty Ltd, has received approval for its investigational new drug application from the U.S. Food and Drug Administration to initiate clinical trials of VGX-100.

31 Oct 2011

Political cartoon: 'Great Pumpkin'

Kaiser Health News provides a fresh perspective on health policy developments with "Great Pumpkin" by Lisa Benson.

31 Oct 2011

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.

31 Oct 2011

Infinity commences two IPI-145 Phase 1 clinical trials for hematologic malignancies

Infinity Pharmaceuticals, Inc. today announced that it has initiated two Phase 1 clinical trials of IPI-145, a potent, orally available inhibitor of phosphoinositide-3-kinase (PI3K) delta and gamma. These two enzymes are implicated in hematologic cancers as well as a broad range of inflammatory conditions, which are the areas of focus within Infinity's PI3K clinical development program.

31 Oct 2011

First Edition: October 31, 2011

In today's headlines, news reports about a key medical group's take on accountable care organizations and how a "merger wave" is hitting the health care sector.

31 Oct 2011

Avanir seeks EMA marketing authorization for NUEDEXTA to treat pseudobulbar affect

Avanir Pharmaceuticals, Inc. announced today that it has submitted an application to the European Medicines Agency seeking marketing authorization for NUEDEXTA (dextromethorphan HBr and quinidine sulfate) for the treatment of pseudobulbar affect.

31 Oct 2011